Onasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan
ABSTRACT Objective There are limited real‐world data regarding the safety and effectiveness of onasemnogene abeparvovec (OA; Zolgensma) infusion, a one‐time gene replacement therapy, for Japanese patients with spinal muscular atrophy (SMA). We aimed to improve understanding of the real‐world outcomes for OA in Japan.
Kayoko Saito +8 more
wiley +1 more source
An Integrated FMEA-RCA Risk-Management Approach for Deep Vein Thrombosis Prevention in Patients Undergoing Total Knee Arthroplasty. [PDF]
Li T +7 more
europepmc +1 more source
DVIA technique for acute periprosthetic joint infection: a surgical technique and case series. [PDF]
Li M +7 more
europepmc +1 more source
Digital Health Technology for Improving Physical Function in Adults With Chronic Heart Failure: Systematic Review and Meta-Analysis of Randomized Controlled Trials. [PDF]
Meng Z +6 more
europepmc +1 more source
Mueller manoeuvre increases the mitral-to-aortic velocity-time integral ratio, a mitral regurgitant index, in patients with dilated cardiomyopathy. [PDF]
Virolainen J, Ventilä M, Kupari M.
europepmc +1 more source
Persistent critical illness in acute hypoxic respiratory failure: A retrospective cohort study. [PDF]
Kalinoski M +5 more
europepmc +1 more source
Related searches:
The purpose of this paper is to enhance the study of the mean time to failure (MTTF) order in an age replacement model, and the decreasing mean time to failure (DMTTF) class of life distributions. We present new characterizations of the MTTF order in terms of the well-known hazard rate and reversed hazard rate orders.
M. Kayid +3 more
openaire +3 more sources

